Researchers

)}
Dott. Matteo Curtarello
Dirigente biologo
Dott.-Matteo-Curtarello
)}
Dott.ssa Valeria Tosello
Dirigente biologo
Tosello
)}
Dott. Erich Piovan
Dirigente medico
Erich-Piovan
Dr.
Dott. Marco Montagna
Dirigente biologo, Responsabile UOS Tumori eredo-familiari della mammella/ovaio
Dott.-Marco-Montagna
)}
Dott.ssa Chiara Menin
Dirigente biologo
Dott.ssa-Chiara-Menin
)}
Dott.ssa Maria Luisa Calabrò
Dirigente biologo
Maria-Luisa-Calabro
Dr.
Prof. Stefano Indraccolo
Professore associato, Responsabile dell’unità operativa
Indraccolo
Dr.
Prof. Vincenzo Ciminale
Dirigente medico, Professore associato, Responsabile dell’unità operativa
ciminale
)}
Dott.ssa Annarosa Del Mistro
Dirigente medico
Dott.ssa-Annarosa-Del-Mistro
Dr.
Prof. Simone Mocellin
Direttore dell’Unità operativa, Dirigente medico, Professore ordinario
Mocellin-Simone

Gruppi di ricerca

CLINICAL RESEARCH GROUP ON BREAST CANCER

ONCOLOGY 2 UNIT

  • Tailoring the treatment in early breast cancer
  • Immunotherapy in breast cancer
  • Identifying prognostic and predictive biomarkers in breast cancer

GASTROINTESTINAL CANCERS CLINICAL RESEARCH GROUP

ONCOLOGY 1 UNIT

  • Development of tailored treatment: one size do not fits all
  • Multidisciplinary approach to the disease
  • New targets for new treatment
  • Immunotherapy is the new frontier

GENITO URINARY ONCOLOGY RESEARCH TEAM

ONCOLOGY 1 UNIT

  • Biomarkers and treatment of patients with Prostate cancer
  • Biomarkers and Treatment of patients with Renal cell carcinoma
  • Immunotherapy and biomarkers in patients with Bladder or Upper Urinary Tract carcinoma
  • Outcome and quality of life of patients with Testicular cancer

GYNECOLOGIC ONCOLOGY CLINICAL RESEARCH GROUP

ONCOLOGY 2 UNIT

  • Multidisciplinary approach to the disease
  • Immunotherapy is the new frontier
  • Real word evidence studies

HEAD AND NECK CANCERS CLINICAL RESEARCH TEAM

ONCOLOGY 2 UNIT

  • Improving the treatment strategies and identifying new prognostic and predictive biomarkers

NETWORK CLINICAL RESEARCH GROUP

ONCOLOGY 2 UNIT

  • Evaluation of the impact of the diagnostic-therapeutic pathways in oncology
  • Regional and National collection of real world data on activity, efficacy, safety and budget impact of innovative anticancer drugs
  • Regional and National prospective clinical studies
  • Administrative health data extraction on diagnosis and treatment of breast and lung cancer

NEURO-ONCOLOGY RESEARCH TEAM

ONCOLOGY 1 UNIT

  • Developing novel therapeutics for the treatment of malignant brain tumors
  • Identifying the right treatment for elderly patients with brain tumors improving their quality of life and neuro-cognitive functions
  • Identifying molecular predictors of treatment benefit in glioblastoma patients
  • New imaging modalities in early disease detection and response assessment to new therapies in glioblastoma patients

ONCO-HAEMATOLOGICAL RESEARCH TEAM

ONCOLOGY 1 UNIT

  • New therapeutic approach in lymphoma
  • Diffuse large B cell lymphoma in elderly patients
  • Molecular prognostic factors in Diffuse Large B cell lymphoma

SARCOMA RESEARCH TEAM

ONCOLOGY 1 UNIT

  • Developing novel therapeutics for the treatment of soft tissue sarcoma and bone tumors
  • Multidisciplinary approach to the disease
  • Identifying the optimal treatment for older patients with advanced soft tissue sarcoma
  • Identifying molecular predictors of treatment benefit in patients with sarcoma

THORACIC MALIGNANCIES CLINICAL RESEARCH TEAM

ONCOLOGY 2 UNIT

  • Improvement of multidisciplinary management of lung cancer, mesothelioma and thymic neoplasms
  • Access to wide molecular characterization and targeted treatment in lung cancer
  • Implementation of liquid biopsy for lung cancer in clinical practice
  • Study of predictive markers for immunotherapy efficacy and toxicity in lung cancer
  • Study of predictive biomarkers and acquired resistance mechanisms in EGFR-mutated advanced NSCLC
Ultimo aggiornamento: 20 Maggio 2025, 09:56